| LINE ITEM (USD / %) | FY 2025
FILED 2025-06-30 | FY 2024
FILED 2024-06-30 | FY 2023
FILED 2023-06-30 |
|---|---|---|---|
| Revenue (Total Sales) | $1.11B | $826.0M | $626.9M |
| YoY Revenue Growth % | +34.9% | +31.8% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$87.3M | -$615.8M | -$1.20B |
| Operating Margin % | -7.8% | -74.6% | -191.5% |
| Net Income (GAAP) | $52.2M | -$517.8M | -$985.3M |
| EBITDA (Normalized) | $66.5M | -$488.4M | -$1.18B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $793.9M | $450.1M | $12.2M |
| Capital Expenditures (CapEx) | $192.2M | $159.3M | $28.2M |
| Free Cash Flow (FCF) | $601.7M | $290.8M | -$16.0M |
| FCF Margin % | 54.0% | 35.2% | -2.6% |
| Return on Invested Capital (ROIC %) | -1.1% | -9.6% | -11.3% |
| Cash & Short-Term Equivalents | $1.53B | $1.20B | — |
| Total Debt (Short + Long Term) | $4.23B | $3.46B | $3.26B |
| Total Stockholders' Equity | $3.55B | $2.79B | $6.70B |